Grants and Contributions:
Title:
Design and development of nanobead-based chemiluminescence immunoassays for automated analyzers
Agreement Number:
1009243
Agreement Value:
$275,000.00
Agreement Date:
Jul 4, 2023 - Mar 31, 2025
Description:
Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 2022–2028 (https://www.vantagemarketresearch.com/industry-report/automated-immunoassay-analyzers-market-1314).. Automated analyzers are one of the main diagnostic platforms in Canada and other developed nations. In line with this market trend, DBC will transfer vital diagnostic hormone assays, a field in which it is a global market leader, from a microplate-based platform to higher throughput automated systems. This initiative will expand the addressable market both locally and globally for DBC products providing sustained double-digit growth well into the future.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
London, Ontario, CA N6M 1A1
Reference Number:
172-2023-2024-Q3-1009243
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
123926966
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 276 days.
Amendment Date
Aug 2, 2024
Recipient's Operating Name:
DBC Labs
Recipient's Legal Name:
Diagnostics Biochem Canada Inc.
Federal Riding Name:
London--Fanshawe
Federal Riding Number:
35051
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
621510
Amendments: